Standout Papers

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analo... 2011 2026 2016 2021 506
  1. Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide (2011)
    Arne Astrup, Raffaele Carraro et al. International Journal of Obesity

Immediate Impact

1 by Nobel laureates 10 from Science/Nature 115 standout
Sub-graph 1 of 19

Citing Papers

Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
2025 Standout
Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?
2024 Standout
21 intermediate papers

Works of Raffaele Carraro being referenced

Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults
2013
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide
2011 Standout

Author Peers

Author Last Decade Papers Cites
Raffaele Carraro 494 363 293 610 412 43 1.7k
Pauli Karhapää 471 327 526 830 164 38 2.0k
Paola Massucco 479 273 252 682 241 63 1.7k
Serkan Tapan 207 281 460 348 262 75 1.4k
N. Vydelingum 907 380 420 582 119 31 2.0k
Dong Cheol Han 314 568 433 320 118 32 2.2k
Uta Schwanebeck 255 258 225 837 122 34 1.6k
Maria S. Svane 665 285 106 730 217 52 1.5k
Ludovico Coppola 359 250 172 261 243 54 1.5k
Dean H. Lockwood 649 609 242 581 100 50 1.8k
Ravi Nistala 338 526 191 776 151 58 2.1k

All Works

Loading papers...

Rankless by CCL
2026